In the US medical devices industry, there were 59 M&A deals announced in Q2 2023, worth a total value of $4.9bn, according to GlobalData’s Deals Database. The $1.8bn acquisition of spectrum plastics group by dupont de nemours was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, M&A activity in The US decreased by 14% in Q2 2023 compared with the previous quarter’s total of $5.7bn and rose by 84% as compared to Q2 2022. Related deal volume decreased by 12% in Q2 2023 versus the previous quarter and was 25% lower than in Q2 2022.
The top-ranked legal advisorss supporting these M&A deals in The US Q2 2023 were Goodwin Procter; Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates; Baker & McKenzie with 4, 4, 3 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.